Is the business good?
How good a business is PSNL?
Personalis, Inc. keeps −159% of every revenue dollar as operating profit, against 7.1% for the median Diagnostics & Research name.
−159%
Operating margin · Diagnostics & Research median 7.1% · 12 months to Q1 2026
- Share count, year on year
- +19%
Share count, year on year · shareholders own a smaller slice than a year ago
- R&D as % of revenue
- 81%
R&D as % of revenue
- Gross margin
- 14%
Gross margin
| Year | Operating margin |
|---|---|
| FY2020 | −54% |
| FY2021 | −76% |
| FY2022 | −178% |
| FY2023 | −150% |
| FY2024 | −81% |
| FY2025 | −126% |
Details›
- Gross margin12 months to Q1 2026
- 14%
- Operating margin12 months to Q1 2026
- −159%
- Net margin12 months to Q1 2026
- −148%
- Free cash flow margin
- −131%
- R&D as % of revenue
- 81%
- Revenue, trailing twelve months
- $65M
- Free cash flow, trailing twelve months
- −$85M
- Net income, trailing twelve months
- −$96M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.
Diagnostics & Research
Ranks #20 of 29 by Smart Score